Clinical Trials Arena on MSN
CERo commences second cohort of AML trial
The open-label, first-in-human Phase I/Ib study is evaluating CER-1236's preliminary safety and efficacy in participants.
PCOS remains a highly prevalent disorder in need of further exploration for its role in long-term health outcomes.
Often confused for a common cold, respiratory syncytial virus (RSV) can in fact be serious and should be studied more closely ...
Increased risk of DENV-infection (primarily DENV3) was observed up to 300 days post-SARS-CoV-2 infection (predominantly ...
Children and young people have higher risks of rare vascular and inflammatory diseases up to 12 months after a first COVID-19 ...
A retrospective analysis of a large cohort of patients with diabetic macular edema showed high prevalence of bilateral ...
An estimated 50% of patients with SLE will develop lupus nephritis in their lifetime, with people of African descent more ...
Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical stage biopharmaceutical company ...
After adjusting for established CVD risk factors, the cohort that experienced the brightest nights had significantly higher ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results